Millions Bought Weight Loss Lies!

Major American retailers like Amazon are peddling weight-loss supplements with outlandish, unsubstantiated claims that prey on desperate consumers, echoing the same deceptive practices President Trump’s FTC has long battled.

Story Snapshot

Which? investigation exposes Amazon, eBay, Temu, Holland & Barrett, and Superdrug selling supplements with misleading weight-loss promises violating ad rules.
Over 50 deceptive listings removed after watchdog complaints, but experts demand stronger oversight to protect families from scams.
FTC has filed 120+ cases in the past decade against supplement fraud, showing billions wasted on ineffective products amid rising demand from GLP-1 drug popularity.
Regulatory bodies like ASA and DHSC reject claims for ingredients like raspberry ketones, yet retailers ignore science for profits.
Trump administration’s focus on curbing fraud aligns with calls for real enforcement against corporate overreach harming everyday Americans.

Investigation Reveals Deceptive Marketing Tactics

Which?, a leading consumer watchdog, examined weight-loss supplements sold by major retailers including Amazon, eBay, Holland & Barrett, Superdrug, and Temu. The probe uncovered products promising rapid fat burning, appetite suppression, and targeted weight loss without scientific backing. These claims directly violate Advertising Standards Authority rules prohibiting specific weight loss amounts or equating supplements to prescription drugs like Ozempic. Retailers hosted listings from brands such as Formula Max 5, Pharmaslim, and Coolkin that ignored Department of Health and Social Care approved health claims registers.

Retailer Responses and Partial Clean-Up

After Which? alerted platforms, Amazon, eBay, and Temu removed violating products. Holland & Barrett shifted items from “fat burners” to “superfood” categories. Superdrug halted sales of flagged supplements and audited its site. More than 50 misleading listings vanished, yet Which? warns systemic gaps persist. A government spokesman affirmed claims must carry scientific proof, with local authorities poised for enforcement. This action protects consumers but highlights inconsistent oversight in a billion-dollar industry.

Expert Analysis Exposes Lack of Evidence

Professor Gunter Kuhnle from Reading University dismissed raspberry ketones’ fat-burning claims, noting scant evidence despite hype. He explained chlorogenic acid in green coffee reduces carb absorption, but common foods do the same, rendering supplements unremarkable. Registered nutritionist Rob Hobson cautioned these products offer minor effects at best, misleading people from proven diet and exercise. Such deception diverts families from real health strategies, fueling frustration with unchecked corporate greed.

Manufacturers like Coolkin claim certifications and Pharmaslim cites UK licensing, yet DHSC rejected identical claims for lacking proof. This mismatch underscores regulatory weaknesses exploited by profit-driven sellers, eroding trust in marketplaces Americans rely on daily.

Broader Implications for American Consumers

The FTC’s 120 cases over the last decade confirm persistent supplement scams, with Americans squandering billions on unproven aids. Health Canada’s alerts on fake GLP-1 drugs reveal global fraud risks amplified by e-commerce. Legitimate makers suffer as deceivers undercut markets. Under President Trump, renewed FTC vigor promises crackdowns, prioritizing working families over globalist laxity that lets big tech platforms harbor lies. Stronger rules safeguard pocketbooks and health from overreaching commerce.

Short-term, heightened scrutiny curbs worst offenders. Long-term, potential laws demand evidence-based ads, easing burdens on healthcare from bogus product fallout. Vulnerable groups face heightened risks, amplifying calls for Trump-era reforms emphasizing personal responsibility and market integrity over deceptive promises.